Low- and middle-income countries (LMICs) face limited resources and competing priorities, making it critical to identify which…
The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.
We support low- and middle-income countries to generate, share and use data to improve antimicrobial usage and encourage investment in antimicrobial resistance (AMR).
Studies & Reports
From Studies & Reports, WHO launches the Global Antibiotic Resistance Surveillance (GLASS) Report 2025 , Date: 23/10/2025
The World Health Organization (WHO) has released its Global Antibiotic Resistance Surveillance Report 2025, revealing that one in six…
Programme Update
From Programme Update, Genomics surveillance and outbreak detection: SeqAfrica empowers AMR researchers , Date: 03/10/2025
In the heart of Africa’s fight against antimicrobial resistance (AMR), the Fleming Fund's SeqAfrica project is transforming the w…
Before the Fleming Fund investment, Papua New Guinea had limited capacity for surveillance of antimicrobial resistance (AMR). Laboratory…
- 26
- Active Country Grants
- 20
- Active Regional Grants
- 321
- Supported surveillance sites
- 25
- Countries we work in (up to)
- 170
- National Action Plans developed with Fleming Fund support
- 155
- Countries have supplied data on use of antimicrobial medicines in animals to WOAH database
The Eastern Regional Hospital in Koforidua (ERHK), Ghana, is an antimicrobial resistance (AMR) surveillance site supported by the Fleming…
In a significant milestone for antimicrobial resistance (AMR) surveillance in Pakistan, the Fleming Fund Country Grant (FFCG), led by DAI,…
The threat of mortality, morbidity, and economic loss associated with antimicrobial resistance (AMR) poses a significant burden on…
Two landmark projects aimed at strengthening the Caribbean’s capacity to fight antimicrobial resistance (AMR) were launched on 5 May, at …